Back to Search Start Over

CTL activation is induced by cross‐linking of TCR/MHC‐peptide‐CD8/p56lckadducts in rafts

Authors :
Doucey, Marie‐Agnès
Legler, Daniel F.
Boucheron, Nicole
Cerottini, Jean‐Charles
Bron, Claude
Luescher, Immanuel F.
Source :
European Journal of Immunology; May 2001, Vol. 31 Issue: 5 p1561-1570, 10p
Publication Year :
2001

Abstract

To investigate the role of the coreceptor CD8 and lipid rafts in cytotoxic T lymphocyte (CTL) activation, we used soluble mono‐and multimeric H‐2Kd‐peptide complexes and cloned S14 CTL specific for a photoreactive derivative of the Plasmodium bergheicircumsporozoite (PbCS) peptide 252–260 [PbCS(ABA)]. We report that activation of CTL in suspension requires multimeric Kd‐PbCS(ABA) complexes co‐engaging TCR and CD8. Using TCR ligand photo‐cross‐linking, we find that monomeric Kd‐PbCS(ABA) complexes promote association of TCR/CD3 with CD8/p56lck. Dimerization of these adducts results in activation of p56lckin lipid rafts, where phosphatases are excluded. Additional cross‐linking further increases p56lckkinase activity, induces translocation of TCR/CD3 and other signaling molecules to lipid rafts and intracellular calcium mobilization. These events are prevented by blocking Src kinases or CD8 binding to TCR‐associated Kdmolecules, indicating that CTL activation is initiated by cross‐linking of CD8‐associated p56lck. They are also inhibited by methyl‐β‐cyclodextrin, which disrupts rafts and by dipalmitoyl phosphatidylethanolamine, which interferes with TCR signaling. Because efficient association of CD8 and p56lcktakes place in rafts, both reagents, though in different ways, impair coupling of p56lckto TCR, thereby inhibiting the initial and essential activation of p56lckinduced by cross‐linking of engaged TCR.

Details

Language :
English
ISSN :
00142980 and 15214141
Volume :
31
Issue :
5
Database :
Supplemental Index
Journal :
European Journal of Immunology
Publication Type :
Periodical
Accession number :
ejs2209336
Full Text :
https://doi.org/10.1002/1521-4141(200105)31:5<1561::AID-IMMU1561>3.0.CO;2-W